NANOVIRICIDES, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
NANOVIRICIDES, INC. (NNVC) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $8.27 thousand as of 2022-06-30, per its 10-K filed 2022-10-13.
Discontinued › Notes › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2022-10-13
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $8.27K.
- 2021-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $8.27K.
- 2020-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $8.27K.
- 2019-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $8.27K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2022-06-30 | $8.27K 10-K · filed 2022-10-13 |
| 2021-06-30 | $8.27K 10-K · filed 2021-10-12 |
| 2020-06-30 | $8.27K 10-K · filed 2020-10-13 |
| 2019-06-30 | $8.27K 10-K · filed 2019-08-23 |
| 2018-06-30 | $8.27K 10-K · filed 2018-10-12 |
| 2017-06-30 | $8.27K 10-K · filed 2017-09-28 |
| 2016-06-30 | $8.27K 10-K · filed 2016-09-16 |
| 2015-06-30 | $8.52K 10-K · filed 2015-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |